AGE-DEPENDENT CHANGES IN SYNAPTIC RAFT DOMAINS AND PLASMA MEMBRANE CA2+ - ATPASE
AGE-DEPENDENT CHANGES IN SYNAPTIC RAFT DOMAINS AND PLASMA MEMBRANE CA2+ - ATPASE
批准号:
7347339
负责人:
MARY L. MICHAELIS
金额:
$25.23万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2013-02-28
关键词:
AffectAgeAgingAlzheimer&aposs DiseaseAntibodiesBindingBrainCa(2+)-Transporting ATPaseCalmodulinCell membraneCell modelCellsCeramidesCholesterolChronicCognitiveComplexCultured CellsDataDementiaDetergentsDiseaseDisruptionElderlyEnvironmentEnzymesExperimental ModelsFluorescenceGangliosidesGlycosphingolipidsGoalsHomeostasisImageImmunoprecipitationImpaired cognitionIn SituIn VitroInterventionKineticsLinkLipid PeroxidationLipidsLocalizedManagement Information SystemsMembraneMembrane MicrodomainsModelingModificationMolecularMolecular BiologyNerve DegenerationNeurodegenerative DisordersNeuronsOxidative StressParkinson DiseasePathologic ProcessesPerformancePlayPopulationPredispositionPreparationPrincipal InvestigatorPrion DiseasesProcessPropertyProteinsRNA InterferenceRattusRegulationRelative (related person)ResistanceRoleSamplingSignal TransductionSiteSphingolipidsStressStructureSynapsesSynaptic MembranesSynaptosomesTechniquesTestingTranscriptional ActivationUp-RegulationVariantage relatedagedaging brainbrain cellbrain tissueenzyme activityexcitotoxicitygenetic manipulationin vivoinsightintracellular protein transportmacromoleculemiddle ageoxidationpreventprogramsprotein localization locationresearch studysarcopenia
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mechanisms underlying the age-related decline in cognitive performance and increased susceptibility to
neurodegenerative diseases are not known, though dysregulation of Ca2+ homeostasis and enhanced
oxidative stress appear to be primary contributors. We have found that a major Ca2+ regulator, the plasma
membrane Ca2+ -ATPase (PMCA), is uniquely sensitive to oxidation and is progressively lost from specific
membrane domains of brain neurons with age. These 'raft' domains create platforms for Ca2+- signaling and
are also known to be sites for the processing of the abnormal proteins associated with neurodegenerative
diseases. The overall goal of this project is to identify the mechanisms that regulate the localization
of PMCA in raft domains and the age-dependent changes underlying the loss of PMCA activity from
rafts. Our hypothesis is that this loss is due to enhanced oxidative stress that leads to agedependent
changes in the proteins and lipids that regulate the activity and localization of PMCA
within rafts. The Aims of this application are to: (1) characterize synaptic membrane rafts from 5, 22 and 34-
mos F344/BNF1 rats in terms of protein and lipid oxidation, raft lipid composition, and effects of in vitro
oxidative stress; (2) use pharmacological and genetic manipulations to elucidate the role of the raft lipid
environment in the membrane localization and kinetic properties of PMCA; (3) determine the role of protein
interactions in localization of PMCA in rafts by identifying PMCA binding partners in raft vs non-raft domains,
determining their levels in membranes from 5, 22, and 34-mos rats, and altering expression of the major
partners in cells to test directly their effects on PMCA localization and activity. Our strategy involves analysis
of in vivo brain aging in parallel with in vitro neuronal models for testing specific mechanisms that may
explain some of the age-dependent alterations. We make extensive use of expertise in lipidomics, protein
identification, and molecular biology available in the Cores, and preliminary data support the feasibility of all
aims. Despite the evidence for involvement of rafts in Ca2+ signaling and for Ca2+ dysregulation in agedependent
neurodegenerative diseases, nothing is known about aging in neuronal rafts. Our studies will
begin to fill that gap and provide new insights into links between aging, altered Ca2+ disposition, oxidative
stress and the enhanced vulnerability of the aging brain to the devastating dementias that affect elderly
populations.
Lav Statement: The proposed studies will enhance our understanding of changes that occur in the aging
brain that make it so vulnerable to cognitive impairment and diseases such as Alzheimer's. The ultimate
goal is to identify what interventions might slow or prevent some of those changes with advancing age.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
-
批准号:7351215
-
项目类别:
-
资助金额:$52.31万
-
财政年份:2008
-
负责人:MARY L. MICHAELIS
-
依托单位:
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
-
批准号:7796649
-
项目类别:
-
资助金额:$55.84万
-
财政年份:2008
-
负责人:MARY L. MICHAELIS
-
依托单位:
ANIMAL MODELS, ELECTRON MICROSCOPY, CELL CULTURE AND MOLECULAR BIOLOGY
-
批准号:7347337
-
项目类别:
-
资助金额:$29.09万
-
财政年份:2008
-
负责人:MARY L. MICHAELIS
-
依托单位:
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
-
批准号:7612113
-
项目类别:
-
资助金额:$55.68万
-
财政年份:2008
-
负责人:MARY L. MICHAELIS
-
依托单位:
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
-
批准号:8195513
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2008
-
负责人:MARY L. MICHAELIS
-
依托单位:
In Vivo Testing of Microtubule-Stabilizing Drugs in Triple Transgenic Mice
-
批准号:7229906
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2006
-
负责人:MARY L. MICHAELIS
-
依托单位:
In Vivo Testing of Microtubule-Stabilizing Drugs
-
批准号:7024801
-
项目类别:
-
资助金额:$15.9万
-
财政年份:2006
-
负责人:MARY L. MICHAELIS
-
依托单位:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES
-
批准号:6650623
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2002
-
负责人:MARY L. MICHAELIS
-
依托单位:
University of Kansas/Haskell Indian Nations University IRCDA Project
-
批准号:7477119
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2002
-
负责人:MARY L. MICHAELIS
-
依托单位:
University of Kansas/Haskell Indian Nations University IRCDA Project
-
批准号:7662335
-
项目类别:
-
资助金额:$54.18万
-
财政年份:2002
-
负责人:MARY L. MICHAELIS
-
依托单位:
University of Kansas/Haskell Indian Nations University IRCDA Project
-
批准号:7896852
-
项目类别:
-
资助金额:$54.94万
-
财政年份:2002
-
负责人:MARY L. MICHAELIS
-
依托单位:
University of Kansas/Haskell Indian Nations University IRCDA Project
-
批准号:8118251
-
项目类别:
-
资助金额:$53.05万
-
财政年份:2002
-
负责人:MARY L. MICHAELIS
-
依托单位:
University of Kansas/Haskell Indian Nations University IRCDA Project
-
批准号:7292157
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2001
-
负责人:MARY L. MICHAELIS
-
依托单位:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES
-
批准号:6347565
-
项目类别:
-
资助金额:$25.7万
-
财政年份:2000
-
负责人:MARY L. MICHAELIS
-
依托单位:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES
-
批准号:6201988
-
项目类别:
-
资助金额:$25.7万
-
财政年份:1999
-
负责人:MARY L. MICHAELIS
-
依托单位:
OXIDATIVE STRESS, AGING AND BRAIN CA++ TRANSPORT SYSTEMS
-
批准号:6201025
-
项目类别:
-
资助金额:$13.26万
-
财政年份:1999
-
负责人:MARY L. MICHAELIS
-
依托单位:
OXIDATIVE STRESS, AGING AND BRAIN CA++ TRANSPORT SYSTEMS
-
批准号:6098641
-
项目类别:
-
资助金额:$13.26万
-
财政年份:1998
-
负责人:MARY L. MICHAELIS
-
依托单位:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES
-
批准号:6108138
-
项目类别:
-
资助金额:$25.7万
-
财政年份:1998
-
负责人:MARY L. MICHAELIS
-
依托单位:
OXIDATIVE STRESS, AGING AND BRAIN CA++ TRANSPORT SYSTEMS
-
批准号:6234546
-
项目类别:
-
资助金额:$13.03万
-
财政年份:1997
-
负责人:MARY L. MICHAELIS
-
依托单位:
CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES
-
批准号:6240731
-
项目类别:
-
资助金额:$23.73万
-
财政年份:1997
-
负责人:MARY L. MICHAELIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: